Kim has engaged with graduates, founders, and executives to help them attain evidence of their own capabilities within biotechnology and healthtech leadership. During this panel discussion, she’ll surface approaches to progressing ecosystem changes and broader market awareness of scientific advancements. 

Her focus is on advancing a whole-of-society awareness of preventable medical harm through human factors, design thinking, and patient education. She brings expertise in regulatory compliance, technology commercialization, safety science, and AI governance.